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a potent hypotensivepeptide, was originally isolatedfrom human
phecchromocyfoma.AM reducesthe blood presaureand the pulmonaty
vascularresistance,and increasespulmonatybloodflow. Recentreports
showedthatAMmRNAandAMreceptormRNAarehighlyexpressedinthe
lungs,suggestinga roleof AM in the pulmonatycirculation.To determine
the clinicalsignificanceof AM in PH,we Investigatedthe relationshipbe-
tweenplasmalevelsof AM and pulmonatyhemodynamicain patientswith
PH.Venousbloodsampleswereobtainedduringcardiaccatheterizationand
plasmalevelsof AM were maasuredby specificredioimmunoassayin
consecutivepatientswithseverePH(8 primary,12chronicthromboembolic
PH, M/F 10/10,46 + 15 yrs, meanpulmonatyarterialpressure:55 + 14
mmHg).The plasmalevelsof AM were significantlyhigherin PHthan in
age-matchednormalcontrols(PH:10.3+9.5, control:5.1+0.4 fmol/mi,p <
0.05),althoughtherewasnocorrelationwithmeanpulmonaryarterialpres-
suretakenas a whole.Thereweresignificantcorrelationsbetweenplasma
IevelsofAMandmeanrightatrialpressure(r= O.74,p < 0.01),strokevolume
(r= -0.63, p < 0.01),total pulmonaryresistance(r= 0.64,p < 0.01)and
atrialnatriureticpeptida(r= 0.61,p e 0.01).Afterthefollowupof oneyear
(mean14+ 4 months),the survivalratewassignificantlylowerin patients
with higherplasmalevelsof AM (> 10fmol/ml)comparedwith thosewith
lowerAM(-40 fmol/ml)(28’%versus92%,p < 0.01).Theseresultssuggest
thatplasmalevelsofAMareelevatedinseverePHandthsttheymayreflect
therfghtventrfcularfailureratherthanthedegreeofPH.Theplasmalevelsof








In patientswith leftventricular(LV)dysfunctionplasmalevelsof natriuretic
peptidesare increasedcorrelatingto the hemodynamicabnormalitiesand
might,therefore,servese indicatorsfor LVdysfunction.Wetestedthe hy-







analysis(ROC).In patientswith LV ejectionfraction(LVEF)s 45Y. (n =
36)bothnANPs,cANP(99-126),andBNP-32weresignificantlyincreased.
NANPwasalsoelevatedinpatientswithhypetiensionandnormalLVEF.The
correlationof nANP(60-96)to LVEF(r= 0.55,p < 0.0001),LVend-diastolic
pressure(r= 0.35,p c O.OUOI),rightatrialandpulmonaryarterypressure
weresupariortothoseof nANP(26-55),cANP(99-126)andBNP-32.There
was no correlationbetweenLVEFand proBNP(22-46) or CNP-22.The
areasunderROCcurvesfor LVEFs 45%were0.617for nANP(60-96),
0.761for nANP(22-56), 0.729for cANP(9S-126)and 0.663for BNP-32
indicatinghighdiagnosticaccuracy,whereaethevaluesfor proBNP(0.515)
andCNP-22(0.525)suggestedweakaccuracies.
.CANP(9*126), nANP(60-96),nANP(26-55)and BNP-32are signif-
icantlycorrelatedto hemodynamicvariablesindicatingLVdysfunctionwith
a euperiorsensitivityof nANP(60-96).However,dueto the largescatterof
normalvalues,plasmalevelsaloneare of limitedvalueas indicatorsof LV
dysfunctionin the individualpatient.







tidea(NPa)areelevatedin LVD,it is unclearwhichonebestmrrelateswith
NYHAandifthisrelationshipremainsinout-patientfollow-up.Thecorrelation
betweenNYHAclassandthe NPsandEFon Visit1and Follow-upwereln-
vestigatadwithinunivariate(UV)andmultlvariate(MV)ordinallogisticmodels
in93patientswithLVD[NYHAI(17),II(36),Ill (27),IV(13)].
Visit 1: Uv MV Follow-up: Uv MV
BNP p=o.0001 0.0001 BNP o.ole4 0.0432
C-ANP 0.0001 0.5638 C-ANP 0.0537 O.$eto
N-ANP 0.0008 0.7187 N-ANP 0.02S4 0.1312
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Thereis growinginterestin the usaof C-terminal(C-ANP)and N-terminal
(N-ANP)atrialand brain(BNP)natriureticpeptidesas diagnosticmarkera
of reducedejectionfraction(EF) which may allow screeningof patienta
(pts)at riskwithoutthe highcrestof echo.However,the predictivevalueof
thesemarkersmustbe comparedto that of data availablefrom a routine
clinicalevaluationincludingEGGandchestradiograph(CXR).Todothis,we
studied304consecutiveout-ptsreferredfor echoto evaluateEF because
of symptomsof or riskfactorsfor reducedEF.Bloodwasdrawnat the time
of echo.Clinicaldata was obtainedfrom chart review.Clinicalpredictors
of reducedEF in the 304 pte wereexaminedand a ecoresyatem(Score
= O-6)wasdevelopedfocusingon simplicity,non-subjectivenatureof the
dataandpredictivevalue.Patientsreceived1pointforeachof thefollowing:
orfhopneaorparoxysmalnocturnaldyspnea;histoiyofheartfailure;historyof
myocerdialinfarction;Q waveor intraventricularconductiondefecton ECG;
cardiothoracicratio> 0.55onCXR;venouscongestionoredemaonCXR.In
thispopulation,the prevalenceof an EFc 45%was i2.5~o. The sensitivity
of a Score>0 for predictingan EF < 45%was 100%witha specificityof
65%.Atthesamelevelofspecificity,thesensitivityof a BNP>40 pg/mlwas
79%,a C-ANP>47 pg/mlwas79%whilea N-ANP>911 pglmlwas55%.
Inptawitha ScoreofO(n= 174),nonehadan EFc 45%.Inptswitha Score
>0 (n = 130),29%hadan EF < 45%.C WhileBNPor C-ANP
mayproveusefulasdiagnosticmarkersin somepteat risk,in this studyof
out-ptsreferredforechoto ruleoutsystolicdysfunction,thepredictivevalue
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